BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago Résultats Semestriels d'Immersion pour 2023/2024 Immersion Résultats Semestriels 2023/2024 Shariiing 2.0 Studiiio Projet HEAT
BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago Semester Immersion Results for 2023/2024 Immersion Shariiing 2.0 Half-year Results 2023/2024 Studio HEAT Project
BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago IMMERSION SA : Bilan du Premier Semestre 2023-2024 Chiffre D'affaires Rapport Financier Visioconférence Hybride Technologie De Réalité Étendue Recherche Européenne
BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago IMMERSION SA: Review of the First Half of 2023-2024 Financial Report Turnover Hybrid Videoconferencing Extended Reality Technology European Research
BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago I.CERAM Reporte la Publication de ses Résultats 2023 et du Document d’Enregistrement Universel I.Ceram Résultats Annuels 2023 Document D'Enregistrement Universel Redressement Judiciaire Report De Publication
BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago I.CERAM Postpones the Publication of its 2023 Results and the Universal Registration Document I.Ceram 2023 Annual Results Universal Registration Document Legal Redress Postponement Of Publication
BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago Covivio révèle son capital social et ses droits de vote au 30 avril 2024 Droits De Vote Réglementation Financière Capital Social Covivio Déclaration De Seuil
BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago Covivio Updates Share Capital and Voting Rights Information Share Capital Voting Rights French Commercial Code Real Estate Covivio
BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago Breakthrough in Treatment for Macular Degeneration Blindness by Mesogen Inc. Biotechnology Healthcare Innovation Mesogen Inc Macular Degeneration Stem Cell Treatment
BRIEF published on 04/30/2024 at 18:05, 1 year 8 months ago Percée dans le traitement de la cécité due à la dégénérescence maculaire par Mesogen Inc. Biotechnologie Innovation En Matière De Soins De Santé Mésogène Inc Dégénérescence Maculaire Traitement Des Cellules Souches
Published on 01/15/2026 at 03:15, 5 minutes ago GEC(R) Langara Receives Approval for 26-Storey Flagship Project
Published on 01/15/2026 at 02:00, 1 hour 20 minutes ago Green Bridge Announces Non-Brokered Private Placement for Gross Proceeds of up to C$4 Million
Published on 01/15/2026 at 01:25, 1 hour 55 minutes ago Reeflex Solutions Inc. Provides Bi-Weekly Status Update on MCTO
Published on 01/15/2026 at 00:45, 2 hours 35 minutes ago Future Fuels Completes Gravity Survey At Hornby; Multiple Priority Anomalies Identified; Marketing Update
Published on 01/14/2026 at 23:40, 3 hours 40 minutes ago Northern Dynasty Announces New Board Member and Audit & Risk Committee Chair
Published on 01/14/2026 at 20:31, 6 hours 49 minutes ago Anemoi International Ltd: Holdings in Company
Published on 01/14/2026 at 18:58, 8 hours 21 minutes ago PNE streamlines project pipeline after a successful year in terms of operations
Published on 01/14/2026 at 18:45, 8 hours 34 minutes ago Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease
Published on 01/14/2026 at 18:15, 9 hours 5 minutes ago CPI PROPERTY GROUP – Results of the Share Buy-back Offer
Published on 01/14/2026 at 17:45, 9 hours 35 minutes ago STEF : Bilan semestriel du contrat de liquidité au 31/12/2025
Published on 01/14/2026 at 17:45, 9 hours 35 minutes ago Bilan semestriel du contrat de liquidité au 31 décembre 2025
Published on 01/14/2026 at 10:26, 16 hours 53 minutes ago Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 01/14/2026 at 08:45, 18 hours 35 minutes ago Arnaud Lagardère appointed Non-Executive Chairman of Lagardère Travel Retail. Frédéric Chevalier succeeds Dag Rasmussen from March 1st 2026
